Lyra Therapeutics, Inc.
NASDAQ:LYRA
0.189 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.195 | 0.598 | 0.532 | 0.146 | 0.544 | 0.458 | 0.41 | 0.011 | 0.359 | 0.407 | 5.367 | 0.271 | 0.014 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 13.264 | 0.136 | 0.085 | 12.368 | 10.799 | 0.284 | 0.222 | 0 | 0.3 | 0.28 | 0.014 | 6.377 | 0.3 | 0.07 | 3.743 | 3.712 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0.195 | -12.666 | 0.396 | 0.061 | -11.824 | -10.341 | 0.126 | -0.211 | 0.359 | 0.107 | 5.087 | 0.257 | -6.363 | -0.3 | -0.07 | -3.743 | -3.712 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 1 | -21.181 | 0.744 | 0.418 | -21.735 | -22.579 | 0.307 | -19.182 | 1 | 0.263 | 0.948 | 0.948 | -454.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 5.902 | 13.264 | 18.102 | 12.181 | 12.368 | 10.799 | 12.596 | 9.451 | 10.048 | 10.793 | 8.505 | 10.342 | 7.077 | 7.505 | 4.77 | 3.743 | 3.712 | 2.103 | 2.964 | 3.011 | 2.841 | 3.416 | 2.764 |
| General & Administrative Expenses
| 3.931 | 5.139 | 5.818 | 4.357 | 5.003 | 4.57 | 5.127 | 4.399 | 5.137 | 4.132 | 3.888 | 3.567 | 4.018 | 3.56 | 3.061 | 3.31 | 2.651 | 2.442 | 1.284 | 1.377 | 1.385 | 0.865 | 0.86 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 3.931 | 5.139 | 5.818 | 4.357 | 5.003 | 4.57 | 5.127 | 4.399 | 5.137 | 4.132 | 3.888 | 3.567 | 4.018 | 3.56 | 3.061 | 3.31 | 2.651 | 2.442 | 1.284 | 1.377 | 1.385 | 0.865 | 0.86 |
| Other Expenses
| 2.804 | 29.286 | 0 | 0 | 0 | 1.592 | 0 | 1.316 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 12.637 | 18.258 | 23.92 | 16.538 | 17.371 | 15.369 | 17.723 | 13.85 | 15.185 | 14.925 | 12.393 | 13.909 | 11.095 | 11.065 | 7.831 | 7.053 | 6.363 | 4.545 | 4.248 | 4.388 | 4.226 | 4.281 | 3.624 |
| Operating Income
| -12.442 | -48.974 | -23.524 | -16.477 | -16.827 | -16.503 | -17.313 | -15.155 | -14.826 | -14.518 | -7.026 | -13.638 | -11.081 | -11.065 | -7.831 | -7.053 | -6.363 | -4.545 | -4.248 | -4.388 | -4.226 | -4.281 | -3.624 |
| Operating Income Ratio
| -63.805 | -81.896 | -44.218 | -112.856 | -30.932 | -36.033 | -42.227 | -1,377.727 | -41.298 | -35.671 | -1.309 | -50.325 | -791.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.576 | 0.855 | 1.086 | 1.338 | 1.192 | 0.897 | 1.072 | 0.933 | 0.06 | 0.034 | 0.014 | 0.021 | 0.026 | 0.026 | 0.029 | 0.032 | 0.029 | 0.005 | 0.016 | 0.035 | 0.063 | 0.08 | 0.035 |
| Income Before Tax
| -11.866 | -48.119 | -22.438 | -15.139 | -15.635 | -15.606 | -16.241 | -14.222 | -14.766 | -14.484 | -7.012 | -13.617 | -11.055 | -11.039 | -7.802 | -7.021 | -6.334 | -4.54 | -4.232 | -4.353 | -4.163 | -4.201 | -3.589 |
| Income Before Tax Ratio
| -60.851 | -80.467 | -42.177 | -103.692 | -28.741 | -34.074 | -39.612 | -1,292.909 | -41.131 | -35.587 | -1.307 | -50.247 | -789.643 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.007 | 0.012 | 0.014 | 0.017 | -0.016 | 0.012 | 0.014 | 0.013 | 0 | -0.068 | -0.014 | -0.278 | -0.026 | -0.026 | -0.029 | -0.032 | -0.029 | -0.005 | -0.016 | -0.035 | -0.063 | -0.08 | -0.035 |
| Net Income
| -11.873 | -48.131 | -22.452 | -15.156 | -15.651 | -15.618 | -16.255 | -14.235 | -14.766 | -14.416 | -6.998 | -13.339 | -11.055 | -11.039 | -7.802 | -7.021 | -6.334 | -4.54 | -4.232 | -4.353 | -4.163 | -4.201 | -3.589 |
| Net Income Ratio
| -60.887 | -80.487 | -42.203 | -103.808 | -28.77 | -34.1 | -39.646 | -1,294.091 | -41.131 | -35.42 | -1.304 | -49.221 | -789.643 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.18 | -0.74 | -0.35 | -0.26 | -0.27 | -0.36 | -0.44 | -0.45 | -0.4 | -0.42 | -0.54 | -1.03 | -0.85 | -0.85 | -0.6 | -0.57 | -0.49 | -0.55 | -0.34 | -0.69 | -0.66 | -0.67 | -0.57 |
| EPS Diluted
| -0.18 | -0.74 | -0.35 | -0.26 | -0.27 | -0.36 | -0.44 | -0.45 | -0.4 | -0.42 | -0.54 | -1.03 | -0.85 | -0.85 | -0.6 | -0.57 | -0.49 | -0.55 | -0.34 | -0.69 | -0.66 | -0.67 | -0.57 |
| EBITDA
| -9.599 | -17.66 | -23.388 | -16.392 | -16.827 | -14.911 | -17.029 | -13.617 | -14.547 | -14.114 | -11.645 | -13.36 | -10.731 | -10.762 | -7.761 | -7.012 | -6.33 | -4.532 | -4.24 | -4.381 | -4.22 | -4.275 | -3.616 |
| EBITDA Ratio
| -49.226 | -29.532 | -43.962 | -112.274 | -30.932 | -29.081 | -41.534 | -1,237.909 | -40.521 | -34.968 | -1.257 | -49.299 | -766.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |